Arvaya Healthcare Limited

Rebranded from Bijoy Hans Limited to Arvaya Healthcare Limited effective 13 July 2026 on BSE, and is pivoting into healthcare through the proposed 100% acquisition of Sushodha Institute of Gastroenterology (SIGPL), a super-specialty gastroenterology hospital in Shivamogga. The deal is valued at about Rs 15.49 crore via a share swap of 38.71 lakh equity shares at Rs 40 each, pending shareholder approval via postal ballot. The acquirer's standalone FY26 revenue is Rs 9.11 crore, with total assets of Rs 140.62 crore and an EBITDA margin of 23.3%. Costs are dominated by other operating expenses at 57.3% of revenue, followed by employee costs at 20.8%, depreciation at 6.8% and materials at 6.8%. The board has also approved a Rights Issue of up to Rs 210 crore and is shifting the registered office from Assam to Maharashtra, while appointing a new Executive Director previously at SeCURE Hospitals, Cloudnine, Vaatsalya, and Vikram Hospitals.